Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/ml…Read More
Shares of Glenmark Pharmaceuticals hit a 52-week low of Rs 467, down 7 per cent on the BSE in the early morning trade on Monday after the US health regulator USFDA cited deficiencies in…Read More
While the pharma industry is booming globally, Manipal Academy of Higher Education (MAHE) started researching new drugs and repurposing old ones for more uses. “The recently installed bio-incubator on its…Read More
Private hospital group Life Healthcare says it raised about R3.7bn by selling its investment in India. The group’s sale of its 49.7% stake in Max Healthcare Institute, to Radiant Life…Read More
Cadila Pharmaceuticals, a global leader in the Pharmaceutical Industry participated in IPHEX 2019, to further enhance its scope by opening new avenues. IPHEX hosted by PHARMEXCIL at the Helipad Ground,…Read More
Day after day, the memos flashing across screens in an Oklahoma courtroom have jarred with the family-friendly public image of Johnson & Johnson, the pharmaceutical giant best known for baby powder and…Read More
Aurobindo Pharma shares fell as much as 8 percent intraday on June 21 after receiving a warning letter from the US health regulator for Srikakulam unit. The stock lost 24 percent…Read More
Drug major Sun Pharmaceutical Industries June 21 said it has received four observations from the US health regulator for its Halol facility in Gujarat. The United States Food and Drug Administration (USFDA)…Read More
Glenmark Pharmaceuticals was up 0.51% to Rs 512.15 at 11:23 IST on the BSE after the company said it received tentative ANDA approval for Clindamycin Phosphate Foam, 1%. The announcement was made before…Read More
Are investors finding pharma stocks a bitter pill to swallow? It certainly seems so. Stocks of pharma companies are undershooting the broader markets and the divergence has been increasing since April 2019….Read More
The Competition and Markets Authority (CMA) has provisionally accused four anti-depressant suppliers: Alissa, Lexon, King and Auden Mckenzie of breaking the law and engaging in anti-competitive conduct. The authority accused competitors King…Read More
ANI Pharmaceuticals has acquired a pipeline of seven development stage generic products from Coeptis Pharmaceuticals for $2.3 million dollars and up to $12 million in additional development and commercial milestones….Read More
Across the country, millions of patients are struggling to afford lifesaving medications. Skyrocketing prescription drug prices and price-gouging efforts by the big drug companies are leaving families cash-strapped and desperate…Read More
With the National Company Law Tribunal (NCLT) yet to decide on Dhanuka Laboratories’ resolution plan for Orchid Pharma’s insolvency process, Chennai-based Accord Life Spec Pvt Ltd on Wednesday told the tribunal that…Read More
Aditya Birla Sun Life Mutual Fund has launched Aditya Birla Sun Life Pharma & Healthcare Fund, an open ended equity scheme that will invest in pharma and healthcare services sector….Read More
